Latest Morning Briefing Stories
Tuition-Free Med School Touches Off Multimillion-Dollar Debate
NYU’s promise to help keep medical students debt-free generates joy on campus. But critics question whether it is the best way to recruit a more diverse student pool or get young doctors to commit to primary care.
Podcast: KHN’s ‘What The Health?’ Opioids, EpiPens And Health Funding
In this episode of KHN’s “What the Health?” Julie Rovner of Kaiser Health News, Alice Ollstein of Talking Points Memo, Margot Sanger-Katz of The New York Times and Joanne Kenen of Politico discuss Senate action on health funding and opioid legislation, the state of the individual insurance market and consternation over expiration dates on EpiPens, the self-injected allergy remedy. Also, could an otter with asthma signal a potential public health crisis?
A Black Eye For Blue Shield: Consumers Lash Out Over Coverage Lapses
California’s third-largest insurer faces anger from customers in the individual market who unexpectedly lost their insurance despite paying premiums faithfully. In its recently filed lawsuit, the company blamed a contractor for “egregious” billing problems.
Polémica por aprobación de la FDA de una app “natural” para control de la natalidad
Natural Cycles guía a la mujer para que registre su temperatura corporal y su ciclo menstrual, con el fin de estimar cuáles son los días de ovulación.
Biorhythms And Birth Control: FDA Stirs Debate By Approving ‘Natural’ App
Critics worry about the message federal officials are sending by approving a new birth control option, which uses a mobile phone app for women to track their body temperature and menstrual cycle to avoid pregnancy. But the more choices the better, some reproductive health experts say.
Hospitals Battle For Control Over Fast-Growing Heart-Valve Procedure
Medicare limits payments for valve replacement via a catheter to hospitals with large numbers of heart procedures. But smaller facilities are crying foul.
Purdue Pharma’s Sales Pitch Downplayed Risks Of Opioid Addiction
Through a widely circulated brochure and a videotape of testimonials, the maker of OxyContin stressed patients’ right to opioid treatment for pain.
Shortage Of Insurance Fraud Cops Sparks Campaign Debate
About a quarter of fraud investigator positions at the state Department of Insurance are open, and Steve Poizner has made the vacancies a focus of his campaign for insurance commissioner. His opponent, Ricardo Lara, says chasing criminals isn’t the only solution to rising health care costs.
Energy-Hog Hospitals: When They Start Thinking Green, They See Green
Some hospitals have taken steps to be more energy-efficient. Though at times these changes barely represent rounding errors in their budgets, comprehensive efforts are beginning to make a difference.
Financial Ties That Bind: Studies Often Fall Short On Conflict-Of-Interest Disclosures
A new study in JAMA Surgery finds that a large sample of published medical research failed to disclose details on the financial relationships between medical device makers and physicians. Changes in the disclosure process could close this loop.
Medicaid Officials Target Home Health Aides’ Union Dues
Federal officials are proposing a rule to prohibit home health aides paid directly by Medicaid from having their dues for the powerful Service Employees International Union automatically deducted from their paychecks. The effort would likely mean those workers are far less likely to pay dues and could diminish the union’s influence.
Advances In Treating Hep C Lead To New Option For Transplant Patients
The opioid epidemic has increased the number of donated organs. Until recently, though, organs from donors who died of drug overdoses were often discarded because an estimated 30 percent of them were infected with hepatitis C.
Must-Reads Of The Week From Brianna Labuskes
Newsletter editor Brianna Labuskes wades through hundreds of health articles from the week so you don’t have to.
Podcast: KHN’s ‘What The Health?’ Coming Soon: ‘Long-Term Short-Term’ Plans
In this episode of KHN’s “What the Health?” Julie Rovner of Kaiser Health News, Anna Edney of Bloomberg News, Margot Sanger-Katz of The New York Times and Kimberly Leonard of the Washington Examiner talk about the latest Trump administration efforts to address high drug prices, what’s next for short-term health insurance plans and insider trading charges against a New York GOP congressman.
Sospechas de fraude al Medicare y riesgos por cremas para el dolor preparadas en farmacias
En total, 547 farmacias (casi el 23% de las que envían la mayoría de las facturas a Medicare por hacer estas cremas) recibieron uno o más de las cinco alertas rojas establecidas por los investigadores.
Lax Oversight Leaves Surgery Center Regulators And Patients In The Dark
A Kaiser Health News and USA Today Network investigation finds that a hodgepodge of state rules governing outpatient centers allow some deaths and serious injuries to go unexamined. And no rule stops a doctor exiled by a hospital for misconduct from opening a surgery center down the street.
Pharmacy-Made Pain Creams Flagged On Fears Of Medicare Fraud And Risk
Inspector general identifies possible problems in nearly 23 percent of pharmacies that bill Medicare for blended creams, gels and lotions.
As An Investor In Biotech Stock, Republican Chris Collins May Have Overshared
Rep. Chris Collins talked one time too many, according to federal prosecutors who on Wednesday charged him with violating insider trading laws.
Medicaid Expansion Making Diabetes Meds More Accessible To Poor, Study Shows
The number of diabetes drug prescriptions filled for low-income people enrolled in Medicaid rose sharply in states that expanded eligibility for the program under the Affordable Care Act, according to a new study.
La otra crisis de Puerto Rico: más de un millón en riesgo por recortes a Medicaid
La isla, que todavía está recuperándose de las tormentas de 2017, sufrirá un nuevo revés sanitario: fuertes recortes a Medicaid pueden impactar en la atención médica de los más vulnerables.
